{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:12:51Z","timestamp":1789683171616,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ribitol-phosphate modification is crucial for the functional maturation of \u03b1-dystroglycan. Its dysfunction is associated with muscular dystrophy, cardiomyopathy, and central nervous system abnormalities; however, no effective treatments are currently available for diseases caused by ribitol-phosphate defects. In this study, we demonstrate that prodrug treatments can ameliorate muscular dystrophy caused by defects in <jats:italic>isoprenoid synthase domain containing<\/jats:italic> (<jats:italic>ISPD<\/jats:italic>), which encodes an enzyme that synthesizes CDP-ribitol, a donor substrate for ribitol-phosphate modification. We generated skeletal muscle-selective <jats:italic>Ispd<\/jats:italic> conditional knockout mice, leading to a pathogenic reduction in CDP-ribitol levels, abnormal glycosylation of \u03b1-dystroglycan, and severe muscular dystrophy. Adeno-associated virus-mediated gene replacement experiments suggested that the recovery of CDP-ribitol levels rescues the ISPD-deficient pathology. As a prodrug treatment strategy, we developed a series of membrane-permeable CDP-ribitol derivatives, among which tetraacetylated CDP-ribitol ameliorated the dystrophic pathology. In addition, the prodrug successfully rescued abnormal \u03b1-dystroglycan glycosylation in patient fibroblasts. Consequently, our findings provide proof-of-concept for supplementation therapy with CDP-ribitol and could accelerate the development of therapeutic agents for muscular dystrophy and other diseases caused by glycosylation defects.<\/jats:p>","DOI":"10.1038\/s41467-022-29473-4","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:02:54Z","timestamp":1649930574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0789-1697","authenticated-orcid":false,"given":"Hideki","family":"Tokuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Imae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Manya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-147X","authenticated-orcid":false,"given":"Kazuhiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Lefeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2910-3797","authenticated-orcid":false,"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamao","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-6398","authenticated-orcid":false,"given":"Motoi","family":"Kanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0717-1123","authenticated-orcid":false,"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"29473_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1242\/jcs.02814","volume":"119","author":"R Barresi","year":"2006","unstructured":"Barresi, R. & Campbell, K. P. Dystroglycan: from biosynthesis to pathogenesis of human disease. J. Cell Sci. 119, 199\u2013207 (2006).","journal-title":"J. Cell Sci."},{"key":"29473_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nrm2024","volume":"7","author":"KE Davies","year":"2006","unstructured":"Davies, K. E. & Nowak, K. J. Molecular mechanisms of muscular dystrophies: old and new players. Nat. Rev. Mol. Cell Biol. 7, 762\u2013773 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"29473_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1741-4520.2003.tb01033.x","volume":"43","author":"T Toda","year":"2003","unstructured":"Toda, T. et al. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy. Congenit. Anom. (Kyoto) 43, 97\u2013104 (2003).","journal-title":"Congenit. Anom. (Kyoto)"},{"key":"29473_CR4","doi-asserted-by":"publisher","first-page":"15457","DOI":"10.1074\/jbc.R200031200","volume":"278","author":"DE Michele","year":"2003","unstructured":"Michele, D. E. & Campbell, K. P. Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function. J. Biol. Chem. 278, 15457\u201315460 (2003).","journal-title":"J. Biol. Chem."},{"key":"29473_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/jb\/mvy020","volume":"163","author":"M Kanagawa","year":"2018","unstructured":"Kanagawa, M. & Toda, T. Ribitol-phosphate-a newly identified posttranslational glycosylation unit in mammals: structure, modification enzymes and relationship to human diseases. J. Biochem. 163, 359\u2013369 (2018).","journal-title":"J. Biochem."},{"key":"29473_CR6","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/glycob\/cwx062","volume":"27","author":"MO Sheikh","year":"2017","unstructured":"Sheikh, M. O., Halmo, S. M. & Wells, L. Recent advancements in understanding mammalian O-mannosylation. Glycobiology 27, 806\u2013819 (2017).","journal-title":"Glycobiology"},{"key":"29473_CR7","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1074\/jbc.272.4.2156","volume":"272","author":"A Chiba","year":"1997","unstructured":"Chiba, A. et al. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J. Biol. Chem. 272, 2156\u20132162 (1997).","journal-title":"J. Biol. Chem."},{"key":"29473_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1180512","volume":"327","author":"T Yoshida-Moriguchi","year":"2010","unstructured":"Yoshida-Moriguchi, T. et al. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327, 88\u201392 (2010).","journal-title":"Science"},{"key":"29473_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1214115","volume":"335","author":"K Inamori","year":"2012","unstructured":"Inamori, K. et al. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335, 93\u201396 (2012).","journal-title":"Science"},{"key":"29473_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/glycob\/cwv021","volume":"25","author":"T Yoshida-Moriguchi","year":"2015","unstructured":"Yoshida-Moriguchi, T. & Campbell, K. P. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology 25, 702\u2013713 (2015).","journal-title":"Glycobiology"},{"key":"29473_CR11","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","volume":"14","author":"M Kanagawa","year":"2016","unstructured":"Kanagawa, M. et al. Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy. Cell Rep. 14, 2209\u20132223 (2016).","journal-title":"Cell Rep."},{"key":"29473_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/28653","volume":"394","author":"K Kobayashi","year":"1998","unstructured":"Kobayashi, K. et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388\u2013392 (1998).","journal-title":"Nature"},{"key":"29473_CR13","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1086\/324412","volume":"69","author":"M Brockington","year":"2001","unstructured":"Brockington, M. et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 69, 1198\u20131209 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"29473_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ng.2253","volume":"44","author":"T Roscioli","year":"2012","unstructured":"Roscioli, T. et al. Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of alpha-dystroglycan. Nat. Genet. 44, 581\u2013585 (2012).","journal-title":"Nat. Genet."},{"key":"29473_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ng.2252","volume":"44","author":"T Willer","year":"2012","unstructured":"Willer, T. et al. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat. Genet. 44, 575\u2013580 (2012).","journal-title":"Nat. Genet."},{"key":"29473_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.chembiol.2015.10.014","volume":"22","author":"M Riemersma","year":"2015","unstructured":"Riemersma, M. et al. Human ISPD is a cytidyltransferase required for dystroglycan O-mannosylation. Chem. Biol. 22, 1643\u20131652 (2015).","journal-title":"Chem. Biol."},{"key":"29473_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11534","volume":"7","author":"I Gerin","year":"2016","unstructured":"Gerin, I. et al. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto alpha-dystroglycan. Nat. Commun. 7, 11534 (2016).","journal-title":"Nat. Commun."},{"key":"29473_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/brain\/aws312","volume":"136","author":"S Cirak","year":"2013","unstructured":"Cirak, S. et al. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain 136, 269\u2013281 (2013).","journal-title":"Brain"},{"key":"29473_CR19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ajhg.2012.10.009","volume":"91","author":"S Vuillaumier-Barrot","year":"2012","unstructured":"Vuillaumier-Barrot, S. et al. Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly. Am. J. Hum. Genet. 91, 1135\u20131143 (2012).","journal-title":"J. Hum. Genet."},{"key":"29473_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0428-8","volume":"15","author":"F Magri","year":"2015","unstructured":"Magri, F. et al. ISPD mutations account for a small proportion of italian limb girdle muscular dystrophy cases. BMC Neurol. 15, 172 (2015).","journal-title":"BMC Neurol."},{"key":"29473_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.fob.2014.06.007","volume":"4","author":"AY Lee","year":"2014","unstructured":"Lee, A. Y. & Lloyd, K. C. Conditional targeting of Ispd using paired Cas9 nickase and a single DNA template in mice. FEBS Open Bio. 4, 637\u2013642 (2014).","journal-title":"FEBS Open Bio"},{"key":"29473_CR22","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1242\/dev.127.23.5059","volume":"127","author":"MD Tallquist","year":"2000","unstructured":"Tallquist, M. D., Weismann, K. E., Hellstrom, M. & Soriano, P. Early myotome specification regulates PDGFA expression and axial skeleton development. Development 127, 5059\u20135070 (2000).","journal-title":"Development"},{"key":"29473_CR23","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/hmg\/ddt157","volume":"22","author":"M Kanagawa","year":"2013","unstructured":"Kanagawa, M. et al. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression. Hum. Mol. Genet. 22, 3003\u20133015 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"29473_CR24","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1172\/JCI63004","volume":"122","author":"AM Beedle","year":"2012","unstructured":"Beedle, A. M. et al. Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy. J. Clin. Invest. 122, 3330\u20133342 (2012).","journal-title":"J. Clin. Invest."},{"key":"29473_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2796.2009.02158.x","volume":"266","author":"S Tajbakhsh","year":"2009","unstructured":"Tajbakhsh, S. Skeletal muscle stem cells in developmental versus regenerative myogenesis. J. Intern. Med. 266, 372\u2013389 (2009).","journal-title":"J. Intern. Med."},{"key":"29473_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.devcel.2014.11.005","volume":"31","author":"G Comai","year":"2014","unstructured":"Comai, G., Sambasivan, R., Gopalakrishnan, S. & Tajbakhsh, S. Variations in the efficiency of lineage marking and ablation confound distinctions between myogenic cell populations. Dev. Cell 31, 654\u2013667 (2014).","journal-title":"Dev. Cell"},{"key":"29473_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.devcel.2014.11.010","volume":"31","author":"M Haldar","year":"2014","unstructured":"Haldar, M. et al. Response: Contributions of the Myf5-independent lineage to myogenesis. Dev. Cell 31, 539\u2013541 (2014).","journal-title":"Dev. Cell"},{"key":"29473_CR28","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.1021\/acs.jmedchem.5b00737","volume":"58","author":"L Weinschenk","year":"2015","unstructured":"Weinschenk, L., Schols, D., Balzarini, J. & Meier, C. Nucleoside diphosphate prodrugs: Nonsymmetric DiPPro-nucleotides. J. Med. Chem. 58, 6114\u20136130 (2015).","journal-title":"J. Med. Chem."},{"key":"29473_CR29","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"29473_CR30","doi-asserted-by":"publisher","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","volume":"359","author":"CE Dunbar","year":"2018","unstructured":"Dunbar, C. E. et al. Gene therapy comes of age. Science 359, eaan4672 (2018).","journal-title":"Science"},{"key":"29473_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05990-z","volume":"9","author":"MP Cataldi","year":"2018","unstructured":"Cataldi, M. P., Lu, P., Blaeser, A. & Lu, Q. L. Ribitol restores functionally glycosylated alpha-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice. Nat. Commun. 9, 3448 (2018).","journal-title":"Nat. Commun."},{"key":"29473_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.omtm.2019.12.005","volume":"17","author":"MP Cataldi","year":"2020","unstructured":"Cataldi, M. P., Blaeser, A., Lu, P., Leroy, V. & Lu, Q. L. ISPD overexpression enhances ribitol-induced glycosylation of alpha-dystroglycan in dystrophic FKRP mutant mice. Mol. Ther. Methods Clin. Dev. 17, 271\u2013280 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"29473_CR33","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","volume":"26","author":"D Duan","year":"2018","unstructured":"Duan, D. Systemic AAV micro-dystrophin gene therapy for duchenne muscular dystrophy. Mol. Ther. 26, 2337\u20132356 (2018).","journal-title":"Mol. Ther."},{"key":"29473_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/hmg\/ddn387","volume":"18","author":"M Kanagawa","year":"2009","unstructured":"Kanagawa, M. et al. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Hum. Mol. Genet. 18, 621\u2013631 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"29473_CR35","doi-asserted-by":"publisher","first-page":"12573","DOI":"10.1073\/pnas.0906545106","volume":"106","author":"R Han","year":"2009","unstructured":"Han, R. et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc. Natl Acad. Sci. USA 106, 12573\u201312579 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"29473_CR36","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","volume":"6","author":"RT Eastman","year":"2020","unstructured":"Eastman, R. T. et al. Remdesivir: A review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Cent. Sci. 6, 672\u2013683 (2020).","journal-title":"ACS Cent. Sci."},{"key":"29473_CR37","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1373\/clinchem.2019.305391","volume":"65","author":"W van Tol","year":"2019","unstructured":"van Tol, W. et al. Cytidine diphosphate-ribitol analysis for diagnostics and treatment monitoring of cytidine diphosphate-L-ribitol pyrophosphorylase a muscular dystrophy. Clin. Chem. 65, 1295\u20131306 (2019).","journal-title":"Clin. Chem."},{"key":"29473_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood.V97.1.330","volume":"97","author":"K Luhn","year":"2001","unstructured":"Luhn, K., Marquardt, T., Harms, E. & Vestweber, D. Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts. Blood 97, 330\u2013332 (2001).","journal-title":"Blood"},{"key":"29473_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep08316","volume":"5","author":"Y Ohtsuka","year":"2015","unstructured":"Ohtsuka, Y. et al. Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression. Sci. Rep. 5, 8316 (2015).","journal-title":"Sci. Rep."},{"key":"29473_CR40","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/hmg\/ddy032","volume":"27","author":"A Sudo","year":"2018","unstructured":"Sudo, A. et al. Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage. Hum. Mol. Genet. 27, 1174\u20131185 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"29473_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/gt.2011.36","volume":"18","author":"JH Shin","year":"2011","unstructured":"Shin, J. H. et al. Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction. Gene Ther. 18, 910\u2013919 (2011).","journal-title":"Gene Ther."},{"key":"29473_CR42","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1128\/EC.00175-07","volume":"6","author":"DC Turnock","year":"2007","unstructured":"Turnock, D. C. & Ferguson, M. A. Sugar nucleotide pools of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major. Eukaryot. Cell 6, 1450\u20131463 (2007).","journal-title":"Eukaryot. Cell"},{"key":"29473_CR43","doi-asserted-by":"publisher","first-page":"12186","DOI":"10.1074\/jbc.RA118.003197","volume":"293","author":"R Imae","year":"2018","unstructured":"Imae, R. et al. CDP-glycerol inhibits the synthesis of the functional O-mannosyl glycan of alpha-dystroglycan. J. Biol. Chem. 293, 12186\u201312198 (2018).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29473-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:41:14Z","timestamp":1669308074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29473-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["29473"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-29473-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1847"}}